Epidemiology, Staging, Grading, and Risk Stratification of Bladder Cancer

被引:105
作者
Colombel, Marc [1 ]
Soloway, Mark [2 ]
Akaza, Hideyuki [3 ]
Boehle, Andreas [4 ]
Palou, Joan [5 ]
Buckley, Roger [6 ]
Lamm, Donald [7 ]
Brausi, Maurizio [8 ,9 ]
Witjes, J. Alfred [10 ]
Persad, Raj [11 ,12 ]
机构
[1] Univ Lyon 1, Hop Edouard Herriot, Dept Urol, F-69365 Lyon, France
[2] Univ Miami, Sch Med, Dept Urol, Miami, FL USA
[3] Univ Tsukuba, Dept Urol, Tsukuba, Ibaraki, Japan
[4] HELIOS Agnes Karll Hosp, Dept Urol, Bad Schwartau, Germany
[5] Univ Autonoma Barcelona, Fdn Puigvert, Dept Urol, E-08193 Barcelona, Spain
[6] N York Gen Hosp, Dept Urol, Toronto, ON, Canada
[7] Univ Arizona, BCG Oncol, Dept Surg, Phoenix, AZ USA
[8] AUSL Modena Estense Hosp, Dept Urol, Modena, Italy
[9] B Ramazzini Hosp, Modena, Italy
[10] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands
[11] Bristol Urol Inst, Bristol, Avon, England
[12] Bristol Royal Infirm & Gen Hosp, Dept Urol Surg, Bristol, Avon, England
关键词
Bladder cancer risk factors; Epidemiology; Grading; Non-muscle invasive bladder cancer; Risk stratification; Staging;
D O I
10.1016/j.eursup.2008.08.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Context: Understanding the epidemiology and risk factors for non-muscle invasive bladder cancer (NMIBC) can assist: in the prevention and early detection of the disease. Furthermore, staging, grading, and risk stratification are critical for determining the most appropriate management strategies for NMIBC based on risk of recurrence and progression. Objective: To provide community urologists with an overview of the epidemiology of NMIBC as well as current approaches to staging, grading, and risk stratification. Evidence acquisition: A committee of internationally renowned leaders in bladder cancer management, known as the International Bladder Cancer Group (IBCG), identified current key influencing guidelines and published English-language literature related to file epidemiology, staging, and grading of NMIBC available as of March 2008. The IBCG met on four occasions to review the main findings of the identified literature and the current clinical practice guidelines of the European Association of Urology (EAU), the First International Consultation on Bladder Tumors (FICBT), the National Comprehensive Cancer Network (NCCN), and the American Urological Association (AUA). Evidence synthesis: Based on this review, the IBCG provided a summary on the epidemiology of NMIBC and recommendations for the staging, grading, and risk stratification of the disease. Conclusions: Urologists should record the smoking habits of patients and monitor for possible occupational exposure to urothelial carcinogens. The tumour-node-metastases (TNM) classification for tumour staging and both the World Health Organization (WHO) 1973 and 2004 grading systems should be applied for appropriate staging and grading of NMIBC. Urologists should also consider the use of the European Organisation for Research and Treatment of Cancer (EORTC) risk tables for risk stratification of NMIBC based on risk of disease recurrence and progression. (C) 2008 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:618 / 626
页数:9
相关论文
共 59 条
[1]   Segregation analysis of urothelial cell carcinoma [J].
Aben, Katja K. H. ;
Baglietto, Laura ;
Baffoe-Bonnie, Agnes ;
Coebergh, Jan-Willem W. ;
Bailey-Wilson, Joan E. ;
Trink, Barry ;
Verbeek, Andre L. M. ;
Schoenberg, Mark P. ;
Witjes, J. Alfred ;
Kiemeney, Lambertus A. .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (10) :1428-1433
[2]   Familial aggregation of urothelial cell carcinoma [J].
Aben, KKH ;
Witjes, JA ;
Schoenberg, MP ;
Hulsberger-van de Kaa, C ;
Verbeek, ALM ;
Kiemeney, LALM .
INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (02) :274-278
[3]  
*AM CANC SOC, 2006, CANC FACTS FIG 2006
[4]  
American Urological Association, 2007, GUID MAN NONM INV BL
[5]  
[Anonymous], 2006, Cancer epidemiology and prevention
[6]  
BABJUK M, 2008, EUROPEAN ASS UROLOGY
[7]   Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons [J].
Boffetta, P ;
Jourenkova, N ;
Gustavsson, P .
CANCER CAUSES & CONTROL, 1997, 8 (03) :444-472
[8]  
BOHLE A, MANAGEMENT SUPERFICI
[9]   Bladder cancer incidence and risk factors in men with prostate cancer: Results from cancer of the prostate strategic urologic research endeavor [J].
Boorjian, Stephen ;
Cowan, Janet E. ;
Konety, Badrinath R. ;
DuChane, Janeen ;
Tewari, Ashutosh ;
Carroll, Peter R. ;
Kane, Christopher J. .
JOURNAL OF UROLOGY, 2007, 177 (03) :883-887
[10]  
Brennan P, 2000, INT J CANCER, V86, P289, DOI 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO